Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]

Shao Huan Lan; Chih Cheng Lai; Shen Peng Chang; Chun Chun Hsu; Cheng Hsin Chen; Ya Hui Wang; Yueh Lan Huang; Cheng Yi Wang; You Shuei Lin

doi:10.1016/j.jmii.2023.10.003

Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]

Shao Huan Lan
, Chih Cheng Lai
, Shen Peng Chang
, Chun Chun Hsu
, Cheng Hsin Chen
, Ya Hui Wang
, Yueh Lan Huang
, Cheng Yi Wang
, You Shuei Lin

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

Fig. 3[Formula presented] [Table presented] The authors would like to apologise for any inconvenience caused.

原文	英語
頁（從 - 到）	207-208
頁數	2
期刊	Journal of Microbiology, Immunology and Infection
卷	57
發行號	1
DOIs	https://doi.org/10.1016/j.jmii.2023.10.003
出版狀態	已發佈 - 2月 2024

UN SDG

此研究成果有助於以下永續發展目標

SDG 3 良好的健康和福祉

ASJC Scopus subject areas

免疫學和過敏
一般免疫學和微生物學
微生物學（醫學）
傳染性疾病

存取文件

10.1016/j.jmii.2023.10.003

其它文件與鏈接

引用此

Lan, S. H., Lai, C. C., Chang, S. P., Hsu, C. C., Chen, C. H., Wang, Y. H., Huang, Y. L., Wang, C. Y., & Lin, Y. S. (2024). Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]. Journal of Microbiology, Immunology and Infection, 57(1), 207-208. https://doi.org/10.1016/j.jmii.2023.10.003

Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]. / Lan, Shao Huan; Lai, Chih Cheng; Chang, Shen Peng 等.
於: Journal of Microbiology, Immunology and Infection, 卷 57, 編號 1, 02.2024, p. 207-208.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Lan, SH, Lai, CC, Chang, SP, Hsu, CC, Chen, CH, Wang, YH, Huang, YL, Wang, CY & Lin, YS 2024, 'Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]', Journal of Microbiology, Immunology and Infection, 卷 57, 編號 1, 頁 207-208. https://doi.org/10.1016/j.jmii.2023.10.003

Lan SH, Lai CC, Chang SP, Hsu CC, Chen CH, Wang YH 等. Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]. Journal of Microbiology, Immunology and Infection. 2024 2月;57(1):207-208. doi: 10.1016/j.jmii.2023.10.003

Lan, Shao Huan ; Lai, Chih Cheng ; Chang, Shen Peng 等. / Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease : A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]. 於: Journal of Microbiology, Immunology and Infection. 2024 ; 卷 57, 編號 1. 頁 207-208.

@article{7469a186af2e464f8697170f448bce60,

title = "Corrigendum to <{\textquoteleft}Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials{\textquoteright}>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]",

abstract = "Fig. 3[Formula presented] [Table presented] The authors would like to apologise for any inconvenience caused.",

author = "Lan, \{Shao Huan\} and Lai, \{Chih Cheng\} and Chang, \{Shen Peng\} and Hsu, \{Chun Chun\} and Chen, \{Cheng Hsin\} and Wang, \{Ya Hui\} and Huang, \{Yueh Lan\} and Wang, \{Cheng Yi\} and Lin, \{You Shuei\}",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2024",

month = feb,

doi = "10.1016/j.jmii.2023.10.003",

language = "English",

volume = "57",

pages = "207--208",

journal = "Journal of Microbiology, Immunology and Infection",

issn = "1684-1182",

publisher = "Lippincott Williams \& Wilkins Asia",

number = "1",

}

TY - JOUR

T1 - Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease

T2 - A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26–35, (S168411822030253X), (10.1016/j.jmii.2020.11.001)]

AU - Lan, Shao Huan

AU - Lai, Chih Cheng

AU - Chang, Shen Peng

AU - Hsu, Chun Chun

AU - Chen, Cheng Hsin

AU - Wang, Ya Hui

AU - Huang, Yueh Lan

AU - Wang, Cheng Yi

AU - Lin, You Shuei

PY - 2024/2

Y1 - 2024/2

N2 - Fig. 3[Formula presented] [Table presented] The authors would like to apologise for any inconvenience caused.

AB - Fig. 3[Formula presented] [Table presented] The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85174483293

UR - https://www.scopus.com/pages/publications/85174483293#tab=citedBy

U2 - 10.1016/j.jmii.2023.10.003

DO - 10.1016/j.jmii.2023.10.003

M3 - Comment/debate

AN - SCOPUS:85174483293

SN - 1684-1182

VL - 57

SP - 207

EP - 208

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

IS - 1

ER -